Stroma, autor en Stroma Biosciences

Stroma Biosciences Announces Appointment of New Chairman

by Stroma | Jul 15, 2022 | No category, Press releases

Stroma Biosciences, Ltd, a Cambridge based oncology company today announced the appointment of Dr John Beadle as Executive Chairman. Dr Beadle, who previously held the role of CEO at PsiOxus Therapeutics, joins the Stroma Board at a critical time for growth of the...

Stroma accepted as a Milner Therapeutics Institute Frameshift company

by Stroma | Mar 5, 2022 | No category, Press releases

We have been accepted as a Milner Therapeutics Institute Frameshift company providing us with access to state-of-the art of office and lab space in the Cambridge Biomedical Campus (more information found: https://www.milner.cam.ac.uk/ and...

Seed funding investment

by Stroma | Dec 12, 2021 | Publications

We are delighted to have raised seed funding investment from Start Codon. The funding will support the development of our research platform and generation of data for our novel targets. Start Codon link: Startcodon.co

Science Translational medicine Cover

by Stroma | Jan 24, 2020 | Media coverage, No category

Stroma Biosciences co-founders have been accepted as the cover story in Science Translational Medicine for their work on the tumour microenvironment. The research found that treating the normal cells near to the cancer cells with small molecule inhibitors...

Stroma Biosciences

Stroma Biosciences Announces Appointment of New Chairman

Stroma accepted as a Milner Therapeutics Institute Frameshift company

Seed funding investment

Science Translational medicine Cover

Recent Posts